PLG and head and neck cancer: Binding of uPA to uPA receptor (uPAR), which is a glycosyl-phosphatidylinositol (GPI)-anchored cell membrane receptor highly expressed in most types of solid tumors such as breast, prostate, brain, and head and neck cancers, localizes the active uPA to the cell surface and converts its major substrate plasminogen into plasmin.